Intrinsic Value of S&P & Nasdaq Contact Us

DexCom, Inc. DXCM NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
82/100
7/7 Pass
SharesGrow Intrinsic Value
$98.26
+56.1%
Analyst Price Target
$85.82
+36.3%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

DexCom, Inc. (DXCM) reported strong year-over-year revenue growth of +15.6% through 2025-12 (TTM revenue vs prior-year TTM). Net income showed exceptional earnings expansion of +45.1% YoY, reaching $267M in the latest quarter. The net profit margin is 21.2%, which is high. The company has maintained profitability in all 4 quarters. The gross margin is 60% (high), down 0.5pp vs the prior year. With a $25B market cap, MOAT composite score of 76/100 (strong competitive position).

Criteria proven by this page:

  • GROWTH (90/100, Pass) — proving strong growth momentum
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 26-year annual history, the company was profitable in 7 of 26 years — a mixed long-term record
  • INCOME (70/100, Pass) — proves strong profitability and pricing power
  • MOAT (76/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 82/100 with 7/7 criteria passed.

82/100
SG Score
View full scorecard →
VALUE
69/100
Price-to-Earnings & upside
→ IV page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 qtrs profit
EPS $0.67
Proven by this page
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
71/100
Score: 76/100
GM 60% (-0.5pp)
Proven by this page
GROWTH
90/100
Rev +15.6% YoY
NI +45.1% YoY
Proven by this page
INCOME
70/100
Margin 21.2%
$1.3B
Proven by this page
DexCom, Inc. Earnings and Revenue History
Revenue
Earnings & Profit Margin
Metric TTM Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Revenue $4.66B$1.26B$1.21B$1.16B$1.04B
Gross Profit $2.8B$792.7M$731.4M$688.8M$589M
Gross Margin 60.1%62.9%60.5%59.5%56.9%
Operating Income $911.8M$323M$242.5M$212.6M$133.7M
Net Income $836.3M$267.3M$283.8M$179.8M$105.4M
Net Margin 17.9%21.2%23.5%15.5%10.2%
EPS (Diluted) $2.09$0.67$0.70$0.45$0.27
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message